000 01300 a2200397 4500
005 20250512023032.0
264 0 _c19860403
008 198604s 0 0 eng d
022 _a0304-3940
024 7 _a10.1016/0304-3940(86)90051-0
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aPierotti, A R
245 0 0 _aHigh-molecular-weight forms of somatostatin are reduced in Alzheimer's disease and Down's syndrome.
_h[electronic resource]
260 _bNeuroscience letters
_cJan 1986
300 _a141-6 p.
_bdigital
500 _aPublication Type: Comparative Study; Journal Article
650 0 4 _aAge Factors
650 0 4 _aAged
650 0 4 _aAlzheimer Disease
_xmetabolism
650 0 4 _aCholine O-Acetyltransferase
_xmetabolism
650 0 4 _aDown Syndrome
_xmetabolism
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aMale
650 0 4 _aMiddle Aged
650 0 4 _aMolecular Weight
650 0 4 _aPeptides
_xanalysis
650 0 4 _aSomatostatin
_xanalysis
650 0 4 _aSomatostatin-28
650 0 4 _aTemporal Lobe
_xanalysis
700 1 _aHarmar, A J
700 1 _aSimpson, J
700 1 _aYates, C M
773 0 _tNeuroscience letters
_gvol. 63
_gno. 2
_gp. 141-6
856 4 0 _uhttps://doi.org/10.1016/0304-3940(86)90051-0
_zAvailable from publisher's website
999 _c2875303
_d2875303